LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Is Lowering Fennec Pharmaceuticals Inc. (FRX.TO) Q2 26 Estimate To 0.30 From 0.39 3/24/2026 11:09:32 AM
  • Wedbush Is Lowering Fennec Pharmaceuticals Inc. (FRX.TO) Q1 26 Estimate To -0.04 From -0.01 3/24/2026 11:09:22 AM
  • Wedbush Reiterates Fennec Pharmaceuticals Inc. (FRX.TO) At Outperform With $13 Price Target 3/24/2026 11:08:48 AM
  • Fennec Pharma Q4 Net Loss Widens To $5.14 Mln From $1.62 Mln Last Year 3/24/2026 7:08:02 AM
  • Fennec, Cipla Settle PEDMARK Litigation; Generic Entry Deferred Until Sept 2033 3/16/2026 8:37:26 AM
  • Wedbush Reiterates Fennec Pharmaceuticals Inc. (FRX.TO) At Outperform With $13 Price Target 2/20/2026 9:14:59 AM
  • Wedbush Reiterates Fennec Pharmaceuticals Inc. (FRX.TO) At Outperform With $13 Price Target 12/2/2025 7:21:39 PM
  • Fennec Pharmas Announces Positive Topline Results From Clinical Study Of PEDMARK In Japan To Reduce Hearing Loss 12/2/2025 7:11:34 AM
  • Wedbush Is Raising Fennec Pharmaceuticals Inc (FENC) FY 26 Rev. Estimate To 79.2 M From 73.1 M 11/14/2025 11:37:52 PM
  • Wedbush Is Raising Fennec Pharmaceuticals Inc (FENC) Q4 26 Rev. Estimate To 20.1 M From 18.2 M 11/14/2025 11:37:42 PM
  • Wedbush Is Increasing Fennec Pharmaceuticals Inc (FENC) Q3 26 Rev. Estimate To 18.0 M From 16.4 M 11/14/2025 11:37:33 PM
  • Wedbush Is Raising Fennec Pharmaceuticals Inc (FENC) Q2 26 Rev. Estimate To 26.8 M From 25.4 M 11/14/2025 11:37:23 PM
  • Wedbush Is Increasing Fennec Pharmaceuticals Inc (FENC) Q1 26 Rev. Estimate To 14.2 M From 13.1 M 11/14/2025 11:37:15 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap